Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice

NCT01579955 · clinicaltrials.gov ↗

COMPLETED

Status

321

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Haemophilia A With Inhibitors
Haemophilia B With Inhibitors

Interventions

DRUG: eptacog alfa (activated)

Sponsor

Novo Nordisk A/S